June 20, 2014 (HealthDay News) -- A tool to assess "financial toxicity" for cancer patients -- namely, the expense, anxiety and stress of illness-related costs -- has been developed by University of Chicago Medical Center cancer specialists.
The team developed a brief questionnaire after discussions with 150 patients with advanced cancer, according to the study in the July issue of the journal Cancer.
Study mentioned:
Cancer. 2014 Jun 20. doi: 10.1002/cncr.28814. [Epub ahead of print]
The development of a financial toxicity patient-reported outcome in cancer: The COST measure.
de Souza JA1, Yap BJ, Hlubocky FJ, Wroblewski K, Ratain MJ, Cella D, Daugherty CK.
No comments:
Post a Comment